Shaping the Future of Translational Science

Scroll down

While 2020 wasn’t the year any of us had planned, the IBRI continued its work solving some of the most challenging biomedical problems.

From our new home in Innovation Building 1 in the 16 Tech Innovation District, we’re enhancing our integrated capabilities and adding depth to how we approach patient-informed translational science, both independently and through valued collaborations.

researcher filling pipets

researchers looking at results

The IBRI’s new strategic direction reflects the dynamic and evolving role of innovators in the biomedical field and optimizes where we can be best positioned alongside industry and academia to advance science and deliver meaningful outcomes for patients.

From the CEO & President

Alan Palkowitz, PhD

“Our strategic intent will continue on the ambitious path that was envisioned when the IBRI was first founded several years ago but updated for today’s scientific opportunities and environment.”

Read the CEO Letter

Alan Palkowitz

IBRI Office Building

Our research is made possible by your generous gift.

Your donation will help lead to solutions to major health challenges such as diabetes, cardiometabolic disease and poor nutrition.

donate now